ArticleJournal of human hypertension2026
When the sum isn't the whole - The vascular status score and its components in hypertension identification: The African PREDICT study.
Article in Journal of human hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The vascular status score (VSS) is an emerging composite index, developed to investigate early vascular changes by integrating pulse wave velocity (PWV), augmentation index (AIx), and carotid intima-media thickness (cIMT). Although prior studies have linked the VSS to inflammatory and metabolic dysfunction, its association with hypertension remains unexplored. This study compared the ability of the VSS and its individual components in identifying hypertension, regardless of phenotype, among young South African adults. We included 1,019 participants aged 20 - 30 years from a community-based cohort. Office and ambulatory blood pressures were measured, and hypertension phenotypes were defined according to the 2024 ESC guidelines. Carotid-femoral PWV, Aix, and cIMT were assessed and combined to calculate the composite VSS. Receiver operating characteristic (ROC) analyses determined optimal cut points for VSS and its components relative to normotensive and hypertensive classifications, and odds ratios were adjusted for relevant covariates. Among the indices examined, only PWV demonstrated consistent sensitivity and specificity across hypertension phenotypes. While a VSS above 4 modestly increased the odds of masked, sustained, and white-coat hypertension (odds ratios ranging from 1.74 to 2.35, all P < 0.05), only PWV accurately identified masked and sustained hypertension (odds ratios 2.25-2.70, all P < 0.01). Neither AIx nor cIMT achieved comparable diagnostic utility. Despite the promise of a composite vascular index, PWV independently outperformed the VSS and its other components in detecting hypertension in young adults. These findings suggest that PWV may be the most reliable individual biomarker for early hypertension identification in young adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.